Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis

D Ko, F Rahman, RB Schnabel, X Yin… - Nature Reviews …, 2016 - nature.com
Atrial fibrillation (AF) is the most common sustained arrhythmia in women and men
worldwide. During the past century, a range of risk factors has been associated with AF …

Stroke prevention in atrial fibrillation: a systematic review

GYH Lip, DA Lane - Jama, 2015 - jamanetwork.com
Importance Atrial fibrillation (AF) is associated with an increase in mortality and morbidity,
with a substantial increase in stroke and systemic thromboembolism. Strokes related to AF …

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve …

Task Force Members, GYH Lip… - European heart …, 2014 - academic.oup.com
Atrial fibrillation (AF) confers a substantial risk of mortality and morbidity from stroke and
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …

Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a …

PB Nielsen, TB Larsen, F Skjøth, A Gorst-Rasmussen… - Circulation, 2015 - Am Heart Assoc
Background—Intracranial hemorrhage is the most feared complication of oral anticoagulant
treatment. The optimal treatment option for patients with atrial fibrillation who survive an …

The HAS‐BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta‐analysis

W Zhu, W He, L Guo, X Wang, K Hong - Clinical cardiology, 2015 - Wiley Online Library
Our objective was to compare the diagnostic accuracy between the HAS‐BLED score and
any of HEMORR2HAGES, ATRIA, CHADS2, or CHA2DS2‐VASc scores in anticoagulated …

Adherence to oral anticoagulant therapy in patients with atrial fibrillation

V Raparelli, M Proietti, R Cangemi… - Thrombosis and …, 2017 - thieme-connect.com
Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular
atrial fibrillation (NVAF) patients. Effective anticoagulation is important to avoid major …

Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation …

GYH Lip, C Laroche, PM Ioachim… - European heart …, 2014 - academic.oup.com
Abstract Background The EURObservational Research Programme-Atrial Fibrillation
General Registry Pilot Phase (EORP-AF Pilot) provides systematic collection of …

Stroke prevention in atrial fibrillation: an Asian perspective

CE Chiang, KL Wang, GYH Lip - Thrombosis and haemostasis, 2014 - thieme-connect.com
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. In 2050, it is
estimated that there will be 72 million AF patients in Asia, accounting for almost 2.9 million …

Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by …

C Sticherling, F Marin, D Birnie, G Boriani… - Ep …, 2015 - academic.oup.com
Since the advent of the non-vitamin K antagonist oral anticoagulant (NOAC) agents, which
act as direct thrombin inhibitors or inhibitors of Factor Xa, clinicians are provided with …

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a …

G Boriani, I Savelieva, GA Dan, JC Deharo… - Ep …, 2015 - academic.oup.com
The kidney exerts multiple functions, and pathophysiological interactions between the
kidney and the heart have important clinical implications, but it has only recently become …